Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Solid Biosciences Inc SLDB

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic
Solid Biosciences Inc. is a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases. The Company is focused on advancing a portfolio of gene therapy candidates including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, AVB-401 for the treatment of BAG3... see more

Recent & Breaking News (NDAQ:SLDB)

SLDB INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Solid Biosciences Inc. Investors

Business Wire March 19, 2018

INVESTOR ALERT: Kirby McInerney LLP Announces Investigation on Behalf of Solid Biosciences Inc. (SLDB) Investors

Business Wire March 16, 2018

The Week Ahead In Biotech: Earnings, PDUFA Dates And More

Benzinga.com  March 16, 2018

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Solid Biosciences Inc. Investors (SLDB)

Business Wire March 15, 2018

SLDB INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Solid Biosciences Inc. Investors

Business Wire March 15, 2018

INVESTOR ALERT: Investigation of Solid Biosciences, Inc. Announced by Holzer & Holzer

Business Wire March 15, 2018

Mid-Day Market Update: Dow Rises Over 200 Points; Invuity Shares Plummet

Benzinga.com  March 15, 2018

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Coastway Bancorp, Inc. to HarborOne Bancorp, Inc. is Fair to Shareholders –CWAY

Business Wire March 15, 2018

Solid Biosciences Announces Clinical Hold On SGT-001 Phase I/II Clinical Trial For Duchenne Muscular Dystrophy

GlobeNewswire March 14, 2018

Solid Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option

GlobeNewswire January 30, 2018

Solid Biosciences Announces Pricing of Initial Public Offering

GlobeNewswire January 25, 2018